oncology

clinical trials

trial name conditions enrollment ends
Adjuvant immunotherapy combination with losartan/toceranib/ladarixin for non-metastatic osteosarcoma osteosarcoma Asparaginase, procarbazine, prednisone, and lomustine for canine multicentric lymphoma lymphoma CAR T cell immunotherapy for treatment of metastatic osteosarcoma in dogs osteosarcoma Combination therapy with gilvetmab and toceranib in dogs with mast cell tumors mast cell tumor Combination trametinib and sapanisertib for canine malignant neoplasia neoplasia COTC027: Preclinical Comparison of Two Hypomethylating Nucleosides in Tumor-Bearing Dogs solid tumor COTC031: Novel immune therapy for dogs with lymphoma or solid tumors solid tumor COTC033: Repurposing vaccine immunity to treat cancers, validation in canine patients neoplasia Evaluation of adaptation time in dogs undergoing limb amputation for osteosarcoma osteosarcoma Focal adhesion kinase inhibition to improve losartan-toceranib immunotherapy in canine metastatic osteosarcoma osteosarcoma Lattice radiation therapy’s effect on the immune response in canine sinonasal carcinoma sinonasal carcinoma Local immune response to radiation therapy and combined myeloid cell targeted therapy in a dog model of sinonasal carcinoma sinonasal carcinoma Novel therapy with LSD-1 inhibitor for cats with oral squamous cell carcinoma oral squamous cell carcinoma Oral melanoma study in dogs oral melanoma Palliative radiation therapy with or without bisphosphonates or carboplatin for dogs with osteosarcoma osteosarcoma Pharmacokinetics of compounded chlorambucil in cats with cancer small cell lymphoma Phase I clinical trial of NIH 972 in dogs with spontaneously occurring sarcomas sarcoma Phase-1 evaluation of vismodegib plus carboplatin in dogs with spontaneous osteosarcoma osteosarcoma Single-dose plasma pharmacokinetic analysis of targeted anticancer agents in tumor-bearing dogs malignant neoplasia The effect of intravenous carboplatin on pain control in dogs with appendicular osteosarcoma osteosarcoma